Evidence map›Paper›PMID 26087178›Full record

ReviewPLoS pathogens2015

Is Development of a Vaccine against Cryptococcus neoformans Feasible?

Chrissy M Leopold Wager, Floyd L Wormley

Abstract readReview
In one paragraph

Review in PLoS pathogens, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Chrissy M Leopold WagerDepartment of Biology, The University of Texas at San Antonio, San Antonio, Texas, United States of America; The South Texas Center for Emerging Infectious Diseases, The University of Texas at San Antonio, San Antonio, Texas, United States of America.
Floyd L WormleyDepartment of Biology, The University of Texas at San Antonio, San Antonio, Texas, United States of America; The South Texas Center for Emerging Infectious Diseases, The University of Texas at San Antonio, San Antonio, Texas, United States of America.

Funding

Protective Host Immunity Against Pulmonary CryptococcosisR01AI071752 · NIAID · UNIVERSITY OF TEXAS SAN ANTONIO · PI WORMLEY, FLOYD L. · 2007 to 2018
$3.7M
Induction of Protection Against Cryptococcus neoformans in Immune Deficient HostsR21AI100893 · NIAID · UNIVERSITY OF TEXAS SAN ANTONIO · PI WORMLEY, FLOYD L. · 2012 to 2013
$393k
NIAID NIH HHS 2R01AI071752NIAID NIH HHS R01 AI071752NIAID NIH HHS R21 AI100893NIAID NIH HHS R21AI100893
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CryptococcosisCryptococcus neoformansFungal VaccinesHumansFungal Vaccines

Identifiers

PMID26087178
PMCPMC4472670

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.